Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome

Clinical Rheumatology - Tập 26 Số 4 - Trang 465-473 - 2007
Mira Meeus1, Jo Nijs1
1Department of Human Physiology, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel (VUB), Brussel, Belgium

Tóm tắt

Từ khóa


Tài liệu tham khảo

Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Strauss SE, Jones JF, Dubois, Cunningham-Rundles C, Pawha S, Tosato G, Zegans LS, Purtilo DT, Brown N, Schooley RT, Brus I (1988) Chronic fatigue syndrome: a working case definition. Ann Intern Med 108:387–389

Fukuda K, Strauss SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff AL; The International Chronic Fatigue Syndrome Study Group (1994). The chronic fatigue syndrome, a comprehensive approach to its definition and study. Ann Intern Med 121:953–959

Buchwald D (1996) Fibromyalgia and chronic fatigue syndrome: similarities and differences. Rheum Dis Clin North Am 22:219–243

Goldenberg DL, Simms RW, Geiger A, Komaroff AL (1990) High frequency of fibromyalgia in patients with chronic fatigue seen in primary care practice. Athritis Rheum 33:387–391

Goldenberg DL (1991) Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 3:247–258

Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, McCready W, Huang CF, Plioplys S (1999) A community-based study of chronic fatigue syndrome. Arch Intern Med 159:2129–2137

Nishikai M, Tomomatsu S, Hankins RW, Takagi S, Miyachi K, Kosaka S, Akiya K (2001) Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary FM: a possible marker for hypersomnia and cognitive disorders. Rheumatology 40:806–810

Nijs J, De Meirleir K, Truyen S (2004) Hypermobility in patients with chronic fatigue syndrome: preliminary observations. J Musculoskelet Pain 12:9–17

Tan EM, Sugura K, Gupta S (2002) The case definition of chronic fatigue syndrome. J Clin Immunol 22:8–12

Nijs J, Vaes P, McGregor N, Van Hoof E, De Meirleir K (2003) Psychometric properties of the Dutch Chronic Fatigue Syndrome—Activities and Participation Questionnaire (CFS-APQ). Phys Ther 83:444–454

Meeus M, Nijs J, De Meirleir K (2006) Chronic musculoskeletal pain in patients with chronic fatigue syndrome: a systematic review. Eur J Pain (in press)

Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russel IJ, Sheon RP (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33:160–172

Komaroff AL, Fagioli LR, Geiger AM, Doolittle TH, Lee J, Kornish RJ, Gleit MA, Guerriero RT (1996) An examination of the working case definition of chronic fatigue syndrome. Am J Med 100:56–64

Nijs J, Van de Velde B, De Meirleir K (2005) Pain in patients with chronic fatigue syndrome: does nitric oxide trigger central sensitization? Med Hypotheses 64:558–562

Bradley LA, McKendree-Smith, Alarcon GS (2000) Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome. Curr Rev Pain 4:148–157

Nijs J, De Meirleir K (2005) Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome. In Vivo 9:1013–1022

Costa DC, Tannock C, Brostoff J (1995) Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 88:767–773

Tirelli U, Chierichetti F, Tavio M, Simonelli C, Bianchin G, Zanco P, Ferlin G (1998) Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 105:54S–58S

Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, Stewart KE, Alarcon GS, Mountz JD (1995) Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38:926–938

Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, Lopez Y, MacKillip F (1994) Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37:1593–1601

Evengard B, Nilsson CG, Lindh G, Lindquist L, Eneroth P, Fredrikson S, Terenius L, Henriksson KG (1998) Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 78:153–155

Winkelstein BA (2004) Mechanisms of central sensitization, neuroimmunology and injury biomechanics in persistent pain: implications for musculoskeletal disorders. J Electromyogr Kinesiol 14:87–93

Merskey H, Bogduk N (1994) Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms, 2nd edn. IASP, Seattle

Staud R (2002) Evidence of involvement of central neural mechanisms in generating FM pain. Curr Rheumatol Rep 4:299–305

Staud R, Smitherman ML (2002) Peripheral and central sensitization in FM: pathogenic role. Curr Pain Headache Rep 6:259–266

Eriksen HR, Ursin H (2004) Subjective health complaints, sensitization, and sustained cognitive activation (stress). J Psychosom Res 56:445–448

Baranauskas G, Nistri A (1998) Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog Neurobiol 54:349–365

DeLeo JA, Winkelstein BA (2002) Physiology of chronic spinal pain syndromes: from animal models to biomechanics. Spine 27:2526–2537

Wall P, Melzack R (1994) Textbook of pain, 3rd edn. Churchill-Livingstone, London

Li J, Simone DA, Larson AA (1999) Windup leads to characteristics of central sensitization. Pain 79:75–82

Coderre TJ, Katz J, Vaccarino AL, Melzack R (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52:259–285

Graven-Nielsen T, Arendt-Nielsen L (2002) Peripheral and central sensitization in musculoskeletal pain disorders: an experimental approach. Curr Rheumatol Rep 4:313–321

Kidd BL, Urban LA (2001) Mechanisms of inflammatory pain. Br J Anaesth 87:3–11

Gracely RH, Grant MA, Giesecke T (2003) Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 17:593–609

Mendell LM, Wall PD (1965) Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 206:97–99

Bennett GJ (2000) Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage 19:S2–S6

Meller ST, Gebhart GF (1993) Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52:127–136

Luo ZD, Cizkova D (2000) The role of nitric oxide in nociception. Curr Rev Pain 4:459–466

Liu H, Brown JL, Jasmin L, Maggio JE, Vigna SR, Mantyh PW, Basbaum AI (1994) Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors. Proc Natl Acad Sci U S A 91:1009–1013

Price DD, Hu JW, Dubner R, Gracely RH (1977) Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain 3:57–68

Dubner R, Ren K (1999) Endogenous mechanisms of sensory modulation. Pain Suppl 6:S45–S53

Wei F, Dubner R, Ren K (1999) Dorsolateral funiculus-lesions unmask inhibitory or disfacilitatory mechanisms which modulate the effects of innocuous mechanical stimulation on spinal Fos expression after inflammation. Brain Res 820:112–116

Ren K, Dubner R (1996) Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation. J Neurophysiol 76:3025–3037

Zusman M (2002) Forebrain-mediated sensitization of central pain pathways: ‘non-specific’ pain and a new image for MT. Man Ther 7:80–88

Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765–1769

Le Bars D, Villanueva L (1988) Electrophysiological evidence for the activation of descending inhibitory controls by nociceptive afferent pathways. Prog Brain Res 77:275–299

Rygh LJ, Tjolsen A, Hole K, Svendsen F (2002) Cellular memory in spinal nociceptive circuitry. Scand J Psychol 43:153–159

Brosschot JF (2002) Cognitive-emotional sensitization and somatic health complaints. Scand J Psychol 43:113–121

Waddell G, Newton M, Henderson I, Somerville D, Main CJ (1993) A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain 52:157–168

Vlaeyen JW, Crombez G (1999) Fear of movement/(re)injury, avoidance and pain disability in chronic low back pain patients. Man Ther 4:187–195

Vlaeyen JW, Linton SJ (2000) Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85:317–332

Turner JA, Jensen MP, Romano JM (2000) Do beliefs, coping, and catastrophizing independently predict functioning in patients with chronic pain? Pain 85:115–125

Treede RD, Meyer RA, Raja SN, Campbell JN (1992) Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 38:397–421

Simms RW, Roy SH, Hrovat M, Anderson JJ, Skrinar G, LePoole SR, Zerbini CA, de Luca C, Jolesz F (1994) Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum 37:794–800

Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD (2001) Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91:165–175

Clauw DJ, Chrousos GP (1997) Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4:134–153

Banic B, Petersen-Felix S, Andersen OK, Radanov BP, Villiger PM, Arendt-Nielsen L, Curatolo M (2004) Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 107:7–15

Koelbaek Johansen M, Graven-Nielsen T, Schou Olesen A, Arendt-Nielsen L (1999) Generalised muscular hyperalgesia in chronic whiplash syndrome. Pain 83:229–234

Price DD, Staud R, Robinson ME, Mauderli AP, Cannon R, Vierck CJ (2002) Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 99:49–59

Sorensen J, Graven-Nielsen T, Henriksson KG, Bengtsson M, Arendt-Nielsen L (1998) Hyperexcitability in fibromyalgia. J Rheumatol 25:152–155

Julien N, Goffaux P, Arsenault P, Marchand S(2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114:295–302

Curatolo M, Petersen-Felix S, Arendt-Nielsen L, Giani C, Zbinden AM, Radanov BP (2001) Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain 17:306–315

Sterling M, Jull G, Vicenzino B, Kenardy J (2003) Sensory hypersensitivity occurs soon after whiplash injury and is associated with poor recovery. Pain 104:509–517

Arendt-Nielsen L, Graven-Nielsen T (2003) Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 7:355–361

Lautenbacher S, Rollman GB (1997) Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13:189–196

Kosek E, Hansson P (1997) Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70:41–51

Lautenbacher S, Rollman GB, McCain (1997) Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 59:45–53

Vierck CJ Jr, Staud R, Price DD, Cannon RL, Mauderli AP, Martin AD (2001) The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome. J Pain 2:334–344

Staud R, Robinson ME, Price DD (2005) Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain 118:176–184

McDermid AJ, Rollman GB, McCain GA (1996) Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain 66:133–144

Crombez G, Baeyens F, Eelen P (1994) Sensory and temporal information about impending pain: the influence of predictability on pain. Behav Res Ther 32:611–622

Waylonis GW, Heck W (1992) Fibromyalgia syndrome. New associations. Am J Phys Med Rehabil 71:343–348

Martin MY, Bradley LA, Alexander RW, Alarcon GS, Triana-Alexander M, Aaron LA, Alberts KR (1996) Coping strategies predict disability in patients with primary fibromyalgia. Pain 68:45–53

Hassett A, Cone JD, Patella SJ, Sigal LH (2000) The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 11:2493–2500

Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ (2003) Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain 102:243–250

Turk DC, Robinson JP, Burwinkle T (2004) Prevalence of fear of pain and activity in patients with fibromyalgia syndrome. J Pain 5:483–490

Willis WD Jr (1997) Nociceptive functions of thalamic neurons. In: Steriade M, Jones EG, McCormick DA (eds) Thalamus: experimental and clinical aspects. Elsevier Science, Oxford, p 373–424

Saade NE, Kafrouni AI, Saab CY, Atweh SF, Jabbur SJ (1999) Chronic thalamotomy increases pain-related behavior in rats. Pain 83:401–409

Chudler EH, Sugiyama K, Dong WK (1993) Nociceptive responses in the neostriatum and globus pallidus of the anesthetized rat. J Neurophysiol 69:1890–1903

Bradley LA, McKendree-Smith, Alberts KR, Alarcon GS, Mountz JM, Deutsch G (2000) Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia. Curr Rheum Rep 2:141–148

Jones AK, Derbyshire SW (1997) Reduced cortical responses to noxious heat in patients with rheumatoid arthritis. Ann Rheum Dis 56:601–607

Hsieh JC, Belfrage M, Stone-Elander S, Hansson P, Ingvar M (1995) Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 63:225–236

Nasralla M, Haier J, Nicolson GL (1999) Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 18:859–865

Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ (2001) Interleukin-1 beta-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471–475

Watkins LR, Maier SF (1999) Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci U S A 96:7710–7713

Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, De Laurentis S, Affaitati G, De Cesare D, Giamberardino MA (2003) Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 335:151–154

Vecchiet L, Montanari G, Pizzigallo E, Iezzi S, de Bigontina P, Dragani L, Vecchiet J, Giamberardino MA (1996) Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome. Neurosci Lett 208:117–120

Whiteside A, Hansen S, Chaudhuri A (2004) Exercise lowers pain threshold in chronic fatigue syndrome. Pain 109:497–499

Vojdani A, Choppa PC, Tagle C, Andrin R, Samini B, Lapp CW (1998) Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol Med Microbiol 22:355–365

Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K (2002) High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunol Med Microbiol 34:209–214

Kurup RK, Kurup PA (2003) Hypothalamic digoxin, cerebral chemical dominance and myalgic encephalomyelitis. Int J Neurosci 113:683–701

Morriss RK, Ahmed M, Wearden AJ, Mullis R, Strickland P, Appleby L, Campbell IT, Pearson D (1999) The role of depression in pain, psychophysiological syndromes and medically unexplained symptoms associated with chronic fatigue syndrome. J Affect Disord 55:143–148

Petrie K, Moss-Morriss R, Weinman J (1995) The impact of catastrophic beliefs on functioning in chronic fatigue syndrome. J Psychosom Res 39:31–37

Sharpe M (1998) Cognitive behavior therapy for chronic fatigue syndrome: efficacy and implications. Am J Med 105:104S–109S

Fischler B, Dendale P, Michiels V, Cluydts R, Kaufman L, De Meirleir K (1997) Physical fatigability and exercise capacity in chronic fatigue syndrome: associations with disability, somatization and psychopathology. J Psychosom Res 42:369–378

Johnson SK, Deluca J, Natelson BH (1996) Assessing somatization disorder in the chronic fatigue syndrome. Psychosom Med 58:50–57

Silver A, Haeney M, Vijayadurai P, Wilks D, Pattrick M, Main CJ (2002) The role of fear of physical movement and activity in chronic fatigue syndrome. J Psychosom Res 52:485–493

Nijs J, De Meirleir K, Duquet W (2004) Kinesiophobia in chronic fatigue syndrome: assessment and associations with disability. Arch Phys Med Rehabil 85:1586–1592

Nijs J, Vanherberghen K, Duquet W, De Meirleir K (2004) Chronic fatigue syndrome: lack of association between pain-related fear of movement and exercise capacity and disability. Phys Ther 84:696–705